NewTimeSpace News: Akesobio announced on August 26 that its self‑developed Ivonescimab (PD‑1/VEGF) in combination with chemotherapy met the primary overall‑survival endpoint in the Phase III trial versus dostarlimab plus chemotherapy for first‑line treatment of advanced biliary tract cancer, delivering positive results with statistically significant and clinically meaningful benefits.
NewTimeSpace News: Breton announced on August 26 that it expects a loss of RMB 80 million to RMB 90 million for the six‑month period ended 30 June 2026, representing a narrowing of loss by approximately 45.93%‑51.67% compared with the same period of last year.
NewTimeSpace News: On 25 August 2026, CMBC CAPITAL (01141.HK) published a clarification announcement stating that the Company's name may have been misappropriated and third parties have claimed association with the Company in suspected investment fraud activities; the Company clarified that none of the Suspected Activities is associated with the Group and that no third party has been authorized to use the Company's name or solicit share investment arrangements, and has reported the matter to the Hong Kong Police Force and forwarded relevant information to regulatory authorities.
NewTimeSpace News: On 25 August 2026, S HARBOURHOLD (01663.HK) announced that its subsidiary Jiangxi Ganghong has entered into a project repayment agreement with independent contractor Gaoneng Construction, which conditionally agreed to accept repayment of the outstanding contract balance of approximately RMB 65 million by instalments with the final instalment due in December 2029; another subsidiary, Leping Runfeng, has mortgaged its land use right in Leping, Jiangxi Province as security, to be released upon full repayment.
NewTimeSpace News: On 25 August 2026, WKK INTL (HOLD) (00532.HK) announced that a subsidiary has agreed to acquire an industrial land of Class B use in Luzhu District, Taoyuan City, Taiwan for TWD 360 million (approximately HKD 90 million), representing a discount of approximately 0.6% to the independent valuation; as the applicable percentage ratios exceed 25% but are below 100%, the acquisition constitutes a major transaction, and written shareholders' approvals from closely connected shareholders holding approximately 50.96% of the issued shares have been obtained under Rule 14.44 of the Listing Rules in lieu of convening a general meeting.
NewTimeSpace News: On 25 August 2026, GOLDWIND (02208.HK) published an overseas regulatory announcement that its board has approved the early dissolution and liquidation of Tianjin Yuanjian Goldwind Ronghe Green Energy No.1 Equity Investment Fund Partnership (Limited Partnership); the Fund has a total size of RMB 800 million with Goldwind's proposed subscription of RMB 159.8 million, with no capital contributions made and no external investment conducted, and the dissolution is due to the failure of the pre-set priority exit channel; the matter will not adversely affect the Company's financial position and results of operations.
NewTimeSpace News: On 25 August 2026, YADONG GROUP (01795.HK) announced the resignation of Mr. Wang Bin as executive director to devote more time to other business and personal affairs, effective from 25 August 2026, with no other positions held in the Company thereafter.
NewTimeSpace News: On 25 August 2026, CHINA TAIPING (00966.HK) announced the appointment of Ms. Chan Ching Ha as independent non-executive director; Ms. Chan, a member of the Executive Council of the HKSAR and a member of the National Committee of the CPPCC, currently serves as Senior Advisor of Deloitte China and Vice Chairman and independent non-executive director of Bank of Communications (Hong Kong) Limited, among other roles, with the appointment not for a specified term and no director's remuneration payable.
NewTimeSpace News: On 25 August 2026, CSPC PHARMA (01093.HK) announced that its recombinant respiratory syncytial virus vaccine (SYS6057) has been approved by the US FDA to conduct clinical trials, following the NMPA approval on 30 July 2026; the product is the Group's second recombinant protein vaccine, with the approved indication of preventing RSV-associated lower respiratory tract disease (LRTD) in people aged 60 and above.
NewTimeSpace News: On 25 August 2026, YANCHANG PETRO (00346.HK) announced that a salesperson of a subsidiary and an independent third party are suspected of conspiring to defraud and misappropriate inventories of approximately RMB 19.24 million (approximately HKD 22.32 million) and have been criminally detained; the incident is still under criminal investigation with the actual financial impact to be confirmed, and was not included in the profit warning announcement dated 4 August 2026; the Company plans to engage third-party professional advisers for an independent investigation.
NewTimeSpace News: August 25, 2026, INNOVENT BIO(01801.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 8.62 billion, increased by 44.76% YoY.
NewTimeSpace News: August 25, 2026, FLAT GLASS(06865.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 6.67 billion, decreased by 13.81% YoY.
NewTimeSpace News: August 25, 2026, GEMDALE PPT(00535.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 1.12 billion, decreased by 82.65% YoY.
August 25, 2026, BOE VARITRONIX(00710.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 7.06 billion, increased by 5.89% YoY
NewTimeSpace News: On 25 August 2026, YADEA (01585.HK) announced that a wholly owned subsidiary has entered into an agreement to acquire 100% of Jinjian Technology Group Co., Ltd. for a total consideration of RMB 1.02 billion, settled in cash and funded by internal resources; the target group is principally engaged in electric bicycles, electric scooters, electric tricycles and related components, with unaudited revenue of approximately RMB 2.68 billion in 2025; the acquisition constitutes a discloseable transaction (highest percentage ratio exceeding 5% but below 25%), exempt from the circular and shareholders' approval requirements.
NewTimeSpace News: August 25, 2026, SINOMAX GROUP(01418.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 2.58 billion, increased by 36.16% YoY.
